Literature DB >> 22440046

Monitoring HSV-TK/ganciclovir cancer suicide gene therapy using CdTe/CdS core/shell quantum dots.

Dan Shao1, Qinghui Zeng, Zheng Fan, Jing Li, Ming Zhang, Youlin Zhang, Ou Li, Li Chen, Xianggui Kong, Hong Zhang.   

Abstract

To be able to label a gene and monitor its migration are key important approaches for the clinical application of cancer suicide gene therapy. Photonic nanomaterials are introduced in this work. One of the most promised suicide genes - herpes simplex virus thymidine kinase (HSV-TK) gene - is successfully linked with CdTe/CdS core/shell quantum dots (QDs) via EDC/NHS coupling method. From confocal microscopy it was demonstrated that plasmid TK intracellular trafficking can be effectively and distinctly traced via monitoring the luminescence of the QDs up to 96 h after transfection of QDs-TK conjugates into Hela cells. MTT results show that the QDs-TK conjugates have a high efficient cytotoxicity after adding GCV into Hela cells, whereas the QDs exert no detectable deleterious effects on the cellular processes. The apoptosis induced by QDs-TK conjugates with GCV is distinctly traced partly due to the strong luminescence of the QDs. Our results indicate that photonic nanomaterials, e.g. QDs, provide a tool for monitoring TK gene delivery and anti-cancer activity.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440046     DOI: 10.1016/j.biomaterials.2012.02.058

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  10 in total

1.  Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy.

Authors:  Sanjay Singh
Journal:  Bioimpacts       Date:  2013-01-14

2.  Meta-analysis of cellular toxicity for cadmium-containing quantum dots.

Authors:  Eunkeu Oh; Rong Liu; Andre Nel; Kelly Boeneman Gemill; Muhammad Bilal; Yoram Cohen; Igor L Medintz
Journal:  Nat Nanotechnol       Date:  2016-02-29       Impact factor: 39.213

3.  Selective inhibition of liver cancer growth realized by the intrinsic toxicity of a quantum dot-lipid complex.

Authors:  Dan Shao; Jing Li; Fengying Guan; Yue Pan; Xuanang Xiao; Ming Zhang; Hong Zhang; Li Chen
Journal:  Int J Nanomedicine       Date:  2014-12-08

Review 4.  Continuing progress toward controlled intracellular delivery of semiconductor quantum dots.

Authors:  Joyce Breger; James B Delehanty; Igor L Medintz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-08-26

Review 5.  Impacts of quantum dots in molecular detection and bioimaging of cancer.

Authors:  Omid Mashinchian; Mohammad Johari-Ahar; Behnaz Ghaemi; Mohammad Rashidi; Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2014-09-27

6.  Introduction of Exogenous HSV-TK Suicide Gene Increases Safety of Keratinocyte-Derived Induced Pluripotent Stem Cells by Providing Genetic "Emergency Exit" Switch.

Authors:  Maciej Sułkowski; Paweł Konieczny; Paula Chlebanowska; Marcin Majka
Journal:  Int J Mol Sci       Date:  2018-01-09       Impact factor: 5.923

7.  A Bioorthogonal Chemical Reporter of Viral Infection.

Authors:  Anne B Neef; Lucile Pernot; Verena N Schreier; Leonardo Scapozza; Nathan W Luedtke
Journal:  Angew Chem Int Ed Engl       Date:  2015-05-14       Impact factor: 15.336

8.  A Bioorthogonal Chemical Reporter of Viral Infection.

Authors:  Anne B Neef; Lucile Pernot; Verena N Schreier; Leonardo Scapozza; Nathan W Luedtke
Journal:  Angew Chem Weinheim Bergstr Ger       Date:  2015-05-14

9.  Berberine-based carbon dots for selective and safe cancer theranostics.

Authors:  Fan Zhang; Ming Zhang; Xiao Zheng; Songyuan Tao; Zhanqiang Zhang; Madi Sun; Yubin Song; Jing Zhang; Dan Shao; Kan He; Jing Li; Bai Yang; Li Chen
Journal:  RSC Adv       Date:  2018-01-03       Impact factor: 4.036

10.  Cytotoxicity of various types of gold-mesoporous silica nanoparticles in human breast cancer cells.

Authors:  Guomu Liu; Qiongshu Li; Weihua Ni; Nannan Zhang; Xiao Zheng; Yingshuai Wang; Dan Shao; Guixiang Tai
Journal:  Int J Nanomedicine       Date:  2015-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.